BREAKING: Flyers lose Oskar Lindbolm for the season after cancer diagnosis
The Philadelphia Flyers announced Friday that forward Oskar Lindbolm will miss the remainder of the season after being diagnosed with Ewing's sarcoma, a form of bone cancer.
Ewing's sarcoma is a very rare type of cancer that grows in your bones or the soft tissue around your bones. It's often found in children and young adults, but older people can also be diagnosed with it. Normally, the survival rate is 70 percentile.
Ewing's sarcoma is a very rare type of cancer that grows in your bones or the soft tissue around your bones. It's often found in children and young adults, but older people can also be diagnosed with it. Normally, the survival rate is 70 percentile.
Philadelphia Flyers forward Oskar Lindbolm has been diagnosed with Ewing's sarcoma by leading specialists at the University of Pennsylvania. He will undergo further testing and evaluation next week and begin treatment immediately thereafter. He is not expected to return to play for the remainder of the season. The Flyers will do everything possible to support Oskar and assist him in securing the best care available. Out of respect for Oskar and his family, the team will have no further comment at this time and asks that Oskar be afforded a period of privacy so that he may focus his efforts on his treatment and return to full health, Flyers President and GM Chuck Fletcher stated.
Post a Comment